Tenaya Therapeutics’ $207 Million Initial Public Offering

Davis Polk advised the representatives of the several underwriters in the offering while Wilson Sonsini Goodrich & Rosati represented Tenaya Therapeutics. Tenaya Therapeutics, Inc. executed the initial…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here